Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Lehmann

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|November 25, 2010
Teaching from catastrophe: using therapeutic misadventures from hydromorphone to teach key principles in clinical pharmacologyDavid F Lehmann
JAMA|April 28, 2005
Arthritis medications and cardiovascular eventsDavid F Lehmann
Clinical Therapeutics|November 24, 2011
Call for a moratorium on routine liver function testing in patients treated with HMG-CoA reductase inhibitors (statins)David F Lehmann
Drug Metabolism Letters|November 20, 2012
The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugsDavid F Lehmann
Journal of Clinical Pharmacology|September 22, 2015
The Evergreening of Biopharmaceuticals: Time to DefoliateDavid F Lehmann, Sarabeth Wojnowicz
The Neurologist|March 2, 2018
Magnesium Sulfate Treatment Correlates With Improved Neurological Function in Posterior Reversible Encephalopathy Syndrome (PRES): Report of a CaseAakriti Pandita, David F Lehmann
Journal of Clinical Pharmacology|October 15, 2011
The seduction of biomarkers in the practice of medicine and the tyranny of power in the drug approval process: lessons from niacinDavid F Lehmann, Daniel S Sitar
Journal of Clinical Pharmacology|July 25, 2008
A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetesDavid F Lehmann, Braj B Lohray
Journal of Clinical Pharmacology|June 14, 2005
The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confoundingPanagiotis A Konstantinopoulos, David F Lehmann
Journal of Clinical Pharmacology|July 21, 2006
Hospital pharmacology: An alternative model for practice and training in clinical pharmacologyDavid F Lehmann, Christine M Stork, Roy Guharoy
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|November 25, 2010
Teaching from catastrophe: using therapeutic misadventures from hydromorphone to teach key principles in clinical pharmacologyDavid F Lehmann
JAMA|April 28, 2005
Arthritis medications and cardiovascular eventsDavid F Lehmann
Clinical Therapeutics|November 24, 2011
Call for a moratorium on routine liver function testing in patients treated with HMG-CoA reductase inhibitors (statins)David F Lehmann
Drug Metabolism Letters|November 20, 2012
The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugsDavid F Lehmann
Journal of Clinical Pharmacology|September 22, 2015
The Evergreening of Biopharmaceuticals: Time to DefoliateDavid F Lehmann, Sarabeth Wojnowicz
The Neurologist|March 2, 2018
Magnesium Sulfate Treatment Correlates With Improved Neurological Function in Posterior Reversible Encephalopathy Syndrome (PRES): Report of a CaseAakriti Pandita, David F Lehmann
Journal of Clinical Pharmacology|October 15, 2011
The seduction of biomarkers in the practice of medicine and the tyranny of power in the drug approval process: lessons from niacinDavid F Lehmann, Daniel S Sitar
Journal of Clinical Pharmacology|July 25, 2008
A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetesDavid F Lehmann, Braj B Lohray
Journal of Clinical Pharmacology|June 14, 2005
The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confoundingPanagiotis A Konstantinopoulos, David F Lehmann
Journal of Clinical Pharmacology|July 21, 2006
Hospital pharmacology: An alternative model for practice and training in clinical pharmacologyDavid F Lehmann, Christine M Stork, Roy Guharoy
Pageof 3